Precision Neuroscience Corp
5 private offerings reported to the SEC on Form D since 2016, $422.3M sold in all. Other health care, NY.
- Form D offerings: 5
- Reported sold: $422.3M
- Newest: Sep 28, 2026
- FDA records: Company page
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Sep 28, 2026 | $250.0M | Open-ended | Precision Neuroscience CorpOther health care · NY | Not amended | 0001123292-26-001327 |
| Oct 17, 2024 | $93.1M | $150.0M | Precision Neuroscience CorpOther health care · NY | Not amended | 0001123292-24-000308 |
| Apr 2, 2024 | $27.5M | $45.0M | Precision Neuroscience CorpOther health care · NY | Not amended | 0001123292-24-000099 |
| Dec 19, 2022 | $41.2M | $42.0M | Precision Neuroscience CorpOther health care · NY | Feb 1, 2023 | 0001567619-22-021752 |
| Apr 28, 2021 | $10.5M | $12.0M | Precision Neuroscience CorpOther health care · NY | Not amended | 0001567619-21-008653 |
SEC Profile
From the company's EDGAR record- Business address
- New York, Ny
- Incorporated in
- DE
- All SEC filings
- CIK 1858288 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR